{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T08:45:48Z","timestamp":1782722748238,"version":"3.54.5"},"reference-count":41,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jpet.2026.104938","type":"journal-article","created":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T23:24:17Z","timestamp":1778282657000},"page":"104938","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Artesunate does not prevent cardiac hypertrophy but inhibits heart failure progression in mice"],"prefix":"10.1016","volume":"393","author":[{"given":"Anna","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoling","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guojun","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1954-7128","authenticated-orcid":false,"given":"Zhiqi","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuefan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5238-1181","authenticated-orcid":false,"given":"Yongsheng","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jpet.2026.104938_bib1","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/nrcardio.2016.25","article-title":"Epidemiology and aetiology of heart failure","volume":"13","author":"Ziaeian","year":"2016","journal-title":"Nat Rev Cardiol"},{"issue":"7","key":"10.1016\/j.jpet.2026.104938_bib2","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1093\/eurheartj\/ehv004","article-title":"Heart failure: the cardiovascular epidemic of the 21st century","volume":"36","author":"L\u00fcscher","year":"2015","journal-title":"Eur Heart J"},{"issue":"20","key":"10.1016\/j.jpet.2026.104938_bib3","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1016\/j.jacc.2017.08.074","article-title":"Heart failure with preserved, borderline, and reduced ejection fraction: 5-year outcomes","volume":"70","author":"Shah","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"36","key":"10.1016\/j.jpet.2026.104938_bib4","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"issue":"16","key":"10.1016\/j.jpet.2026.104938_bib5","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"62","author":"Yancy","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.jpet.2026.104938_bib6","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.pt.2021.08.011","article-title":"Drug-induced hypersensitivity to artemisinin-based therapies for malaria","volume":"38","author":"Nordmann","year":"2022","journal-title":"Trends Parasitol"},{"issue":"2","key":"10.1016\/j.jpet.2026.104938_bib7","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jcv.2013.02.005","article-title":"First therapeutic use of Artesunate in treatment of human herpesvirus 6B myocarditis in a child","volume":"57","author":"Hakacova","year":"2013","journal-title":"J Clin Virol"},{"issue":"20","key":"10.1016\/j.jpet.2026.104938_bib8","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.21037\/atm-20-5182","article-title":"Artesunate alleviates myocardial ischemia\/reperfusion-induced myocardial necrosis in rats and hypoxia\/reoxygenation-induced apoptosis in H9C2 cells via regulating the FAK\/PI3K\/Akt pathway","volume":"8","author":"Fan","year":"2020","journal-title":"Ann Transl Med"},{"issue":"6","key":"10.1016\/j.jpet.2026.104938_bib9","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/SHK.0000000000000963","article-title":"The antimalarial drug artesunate attenuates cardiac injury in a rodent model of myocardial infarction","volume":"49","author":"Khan","year":"2018","journal-title":"Shock"},{"key":"10.1016\/j.jpet.2026.104938_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.176709","article-title":"Artesunate attenuates isoprenaline induced cardiac hypertrophy in rats via SIRT1 inhibiting NF-\u03baB activation","volume":"977","author":"Golatkar","year":"2024","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"10.1016\/j.jpet.2026.104938_bib11","doi-asserted-by":"crossref","DOI":"10.1177\/1559325819897180","article-title":"Cardiotoxicity and cardioprotection by artesunate in larval zebrafish","volume":"18","author":"Zheng","year":"2020","journal-title":"Dose Response"},{"key":"10.1016\/j.jpet.2026.104938_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2023.1263913","article-title":"Transcriptional changes during isoproterenol-induced cardiac fibrosis in mice","volume":"10","author":"Nanda","year":"2023","journal-title":"Front Mol Biosci"},{"key":"10.1016\/j.jpet.2026.104938_bib13","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3389\/fcvm.2019.00068","article-title":"Exercise mediated Nrf2 signaling protects the myocardium from isoproterenol-induced pathological remodeling","volume":"6","author":"Shanmugam","year":"2019","journal-title":"Front Cardiovasc Med"},{"issue":"30","key":"10.1016\/j.jpet.2026.104938_bib14","doi-asserted-by":"crossref","first-page":"15841","DOI":"10.1074\/jbc.M115.684118","article-title":"Loss of mouse P2Y6 nucleotide receptor is associated with physiological macrocardia and amplified pathological cardiac hypertrophy","volume":"291","author":"Clouet","year":"2016","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1016\/j.jpet.2026.104938_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0096892","article-title":"Exercise protects against chronic \u03b2-adrenergic remodeling of the heart by activation of endothelial nitric oxide synthase","volume":"9","author":"Yang","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.jpet.2026.104938_bib16","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.yexmp.2009.10.011","article-title":"The study of ISO induced heart failure rat model","volume":"88","author":"Feng","year":"2010","journal-title":"Exp Mol Pathol"},{"key":"10.1016\/j.jpet.2026.104938_bib17","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.yjmcc.2017.11.012","article-title":"Resident fibroblast expansion during cardiac growth and remodeling","volume":"114","author":"Ivey","year":"2018","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.jpet.2026.104938_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101212","article-title":"Enhanced Keap1-Nrf2 signaling protects the myocardium from isoproterenol-induced pathological remodeling in mice","volume":"27","author":"Shanmugam","year":"2019","journal-title":"Redox Biol"},{"key":"10.1016\/j.jpet.2026.104938_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.106035","article-title":"Current and future therapeutic perspective in chronic heart failure","volume":"175","author":"Mascolo","year":"2022","journal-title":"Pharmacol Res"},{"issue":"2","key":"10.1016\/j.jpet.2026.104938_bib20","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/nrd2219","article-title":"Drug discovery for heart failure: a new era or the end of the pipeline?","volume":"6","author":"Kaye","year":"2007","journal-title":"Nat Rev Drug Discov"},{"issue":"4","key":"10.1016\/j.jpet.2026.104938_bib21","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1080\/17460441.2019.1582636","article-title":"Modeling heart failure in animal models for novel drug discovery and development","volume":"14","author":"Janssen","year":"2019","journal-title":"Expert Opin Drug Discov"},{"issue":"19","key":"10.1016\/j.jpet.2026.104938_bib22","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1056\/NEJM199705083361903","article-title":"Left ventricular dilatation and the risk of congestive heart failure in people without myocardial infarction","volume":"336","author":"Vasan","year":"1997","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.jpet.2026.104938_bib23","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1161\/01.RES.0000265846.23485.7a","article-title":"Inhibition of endogenous Mst1 prevents apoptosis and cardiac dysfunction without affecting cardiac hypertrophy after myocardial infarction","volume":"100","author":"Odashima","year":"2007","journal-title":"Circ Res"},{"issue":"3","key":"10.1016\/j.jpet.2026.104938_bib24","doi-asserted-by":"crossref","first-page":"H552","DOI":"10.1152\/ajpheart.00626.2016","article-title":"Cardiomyocyte-specific ablation of CD36 accelerates the progression from compensated cardiac hypertrophy to heart failure","volume":"312","author":"Sung","year":"2017","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"2","key":"10.1016\/j.jpet.2026.104938_bib25","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/cvr\/cvaa217","article-title":"Metabolic inflammation in heart failure with preserved ejection fraction","volume":"117","author":"Schiattarella","year":"2021","journal-title":"Cardiovasc Res"},{"issue":"5","key":"10.1016\/j.jpet.2026.104938_bib26","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s00011-023-01845-6","article-title":"Inflammation in heart failure: pathophysiology and therapeutic strategies","volume":"73","author":"Boulet","year":"2024","journal-title":"Inflamm Res"},{"issue":"6","key":"10.1016\/j.jpet.2026.104938_bib27","doi-asserted-by":"crossref","first-page":"686","DOI":"10.3390\/antiox13060686","article-title":"Artesunate exerts organ- and tissue-protective effects by regulating oxidative stress, inflammation, autophagy, apoptosis, and fibrosis: a review of evidence and mechanisms","volume":"13","author":"Zhu","year":"2024","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.jpet.2026.104938_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.108413","article-title":"Artesunate attenuates atherosclerosis by inhibiting macrophage M1-like polarization and improving metabolism","volume":"102","author":"Wang","year":"2022","journal-title":"Int Immunopharmacol"},{"issue":"22","key":"10.1016\/j.jpet.2026.104938_bib29","doi-asserted-by":"crossref","first-page":"5474","DOI":"10.3390\/molecules25225474","article-title":"An overview of Nrf2 signaling pathway and its role in inflammation","volume":"25","author":"Saha","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.jpet.2026.104938_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107268","article-title":"Nrf2 mediated signaling axis in heart failure: potential pharmacological receptor","volume":"206","author":"Cheng","year":"2024","journal-title":"Pharmacol Res"},{"issue":"4","key":"10.1016\/j.jpet.2026.104938_bib31","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","article-title":"Ferroptosis: mechanisms, biology and role in disease","volume":"22","author":"Jiang","year":"2021","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.jpet.2026.104938_bib32","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.yjmcc.2022.10.004","article-title":"Ferroptosis in heart failure","volume":"173","author":"Yang","year":"2022","journal-title":"J Mol Cell Cardiol"},{"issue":"1","key":"10.1016\/j.jpet.2026.104938_bib33","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/s12967-023-04734-y","article-title":"Inhibition of ferroptosis reverses heart failure with preserved ejection fraction in mice","volume":"22","author":"Xiong","year":"2024","journal-title":"J Transl Med"},{"key":"10.1016\/j.jpet.2026.104938_bib34","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.canlet.2020.02.015","article-title":"Ferroptosis, a novel pharmacological mechanism of anti-cancer drugs","volume":"483","author":"Su","year":"2020","journal-title":"Cancer Lett"},{"key":"10.1016\/j.jpet.2026.104938_bib35","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.ejpb.2023.07.014","article-title":"Artesunate carriers induced ferroptosis to overcome biological barriers for anti-cancer","volume":"190","author":"Huang","year":"2023","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.jpet.2026.104938_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101107","article-title":"NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis","volume":"23","author":"Dodson","year":"2019","journal-title":"Redox Biol"},{"issue":"2","key":"10.1016\/j.jpet.2026.104938_bib37","doi-asserted-by":"crossref","first-page":"H243","DOI":"10.1152\/ajpheart.00456.2018","article-title":"Estrogen determines sex differences in adrenergic vessel tone by regulation of endothelial \u03b2-adrenoceptor expression","volume":"317","author":"Riedel","year":"2019","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"5","key":"10.1016\/j.jpet.2026.104938_bib38","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1017\/S0007114508025075","article-title":"Sex differences in sensitivity to beta-adrenergic agonist isoproterenol in the isolated adult rat heart following prenatal protein restriction","volume":"101","author":"Elmes","year":"2009","journal-title":"Br J Nutr"},{"key":"10.1016\/j.jpet.2026.104938_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.737003","article-title":"Estrogen attenuates chronic stress-induced cardiomyopathy by adaptively regulating macrophage polarizations via \u03b22-adrenergic receptor modulation","volume":"9","author":"Hou","year":"2021","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"10.1016\/j.jpet.2026.104938_bib40","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cardiores.2005.04.012","article-title":"Myocyte apoptosis in heart failure","volume":"67","author":"van Empel","year":"2005","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jpet.2026.104938_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.740839","article-title":"Catecholamine surges cause cardiomyocyte necroptosis via a RIPK1-RIPK3-dependent pathway in mice","volume":"8","author":"Wu","year":"2021","journal-title":"Front Cardiovasc Med"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356526011377?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356526011377?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T08:09:00Z","timestamp":1782720540000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356526011377"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S0022356526011377"],"URL":"https:\/\/doi.org\/10.1016\/j.jpet.2026.104938","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Artesunate does not prevent cardiac hypertrophy but inhibits heart failure progression in mice","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpet.2026.104938","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104938"}}